INIS
patients
100%
quality of life
100%
photodynamic therapy
100%
losses
42%
distance
42%
eyes
14%
assessments
14%
leakage
14%
sensitivity
14%
vision
14%
fluorescein
14%
outdoors
14%
angiography
14%
Nursing and Health Professions
Quality of Life
100%
Age Related Macular Degeneration
100%
Photodynamic Therapy
100%
Subretinal Neovascularization
50%
Visual Impairment
33%
Visual Acuity
33%
Corrected Distance Visual Acuity
16%
Fluorescence Angiography
16%
Verteporfin
16%
Biochemistry, Genetics and Molecular Biology
Photodynamics
100%
Prospective Study
100%
Vision
100%
Subretinal Neovascularization
50%
Visual Acuity
33%
Contrast Sensitivity
16%
Fluorescein
16%
Corrected Distance Visual Acuity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Study
100%
Photodynamic Therapy
100%
Age Related Macular Degeneration
100%
Subretinal Neovascularization
50%
Visual Impairment
33%
Verteporfin
16%
Fluorescein
16%
Neuroscience
Choroidal Neovascularization
100%
Age-Related Macular Degeneration
100%
Fluorescein
33%
Angiography
33%
Verteporfin
33%